4//SEC Filing
Hindson Benjamin J. 4
Accession 0001610717-23-000222
CIK 0001770787other
Filed
Aug 2, 8:00 PM ET
Accepted
Aug 3, 4:23 PM ET
Size
10.5 KB
Accession
0001610717-23-000222
Insider Transaction Report
Form 4
Hindson Benjamin J.
DirectorSee Remarks
Transactions
- Sale
Class A Common Stock
2023-08-01$62.36/sh−5,243$326,933→ 284,236 total - Exercise/Conversion
Stock Option (right to buy)
2023-08-01−6,970→ 23,312 totalExercise: $11.48Exp: 2029-05-10→ Class A Common Stock (6,970 underlying) - Exercise/Conversion
Class A Common Stock
2023-08-01$11.48/sh+6,970$80,016→ 291,206 total - Sale
Class A Common Stock
2023-08-01$61.77/sh−1,727$106,679→ 289,479 total
Footnotes (4)
- [F1]The transaction reported herein was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on March 13, 2023.
- [F2]This transaction was executed in multiple trades at prices ranging from $61.12 to $62.11. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
- [F3]This transaction was executed in multiple trades at prices ranging from $62.12 to $62.70. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
- [F4]All of the shares subject to the option are fully vested and exercisable as of the date hereof.
Documents
Issuer
10x Genomics, Inc.
CIK 0001770787
Entity typeother
Related Parties
1- filerCIK 0001786391
Filing Metadata
- Form type
- 4
- Filed
- Aug 2, 8:00 PM ET
- Accepted
- Aug 3, 4:23 PM ET
- Size
- 10.5 KB